Schott AG’s finance chief plans to increase spending this year as the specialty glass and materials manufacturer sees growing demand for its products, including syringes and vials for Covid-19 vaccines. The Mainz, Germany-based company intends to invest €450 million, equivalent to about $510 million, this fiscal year. That is up from the €340 million it spent during the year ended Sept. 30.
